Publicacions en col·laboració amb investigadors/es de Hospital Clínico San Carlos de Madrid (9)

2022

  1. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma

    Clinical cancer research : an official journal of the American Association for Cancer Research

  2. Efficiency of screening for human immunodeficiency virus infection in emergency departments: a systematic review and meta-analysis

    Emergencias, Vol. 34, Núm. 3, pp. 204-212

2020

  1. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma

    Blood, Vol. 136, Núm. 2, pp. 199-209

2010

  1. BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)

    Annals of Hematology, Vol. 89, Núm. 5, pp. 453-458

2009

  1. High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics

    Leukemia Research, Vol. 33, Núm. 12, pp. 1706-1709

  2. Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

    Blood, Vol. 114, Núm. 1, pp. 148-152

  3. The EuroPrevall surveys on the prevalence of food allergies in children and adults: Background and study methodology

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 64, Núm. 10, pp. 1493-1497

2008

  1. Lessons learned from long-term university training in minimally invasive surgery in spain

    Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, Vol. 18, Núm. 6, pp. 583-588

2000

  1. Oncoproteína p185 (Neu) en el pronóstico del carcinoma vesical. Experiencia a 5 años

    Archivos Espanoles de Urologia, Vol. 53, Núm. 3, pp. 238-244